| DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants J Piñero, À Bravo, N Queralt-Rosinach, A Gutiérrez-Sacristán, J Deu-Pons, ... Nucleic acids research, gkw943, 2016 | 1410 | 2016 |
| The DisGeNET knowledge platform for disease genomics: 2019 update J Piñero, JM Ramírez-Anguita, J Saüch-Pitarch, F Ronzano, E Centeno, ... Nucleic acids research 48 (D1), D845-D855, 2020 | 777 | 2020 |
| DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes J Piñero, N Queralt-Rosinach, À Bravo, J Deu-Pons, A Bauer-Mehren, ... Database 2015, 2015 | 773 | 2015 |
| Extraction of relations between genes and diseases from text and large-scale data analysis: implications for translational research À Bravo, J Piñero, N Queralt-Rosinach, M Rautschka, LI Furlong BMC bioinformatics 16 (1), 1-17, 2015 | 166 | 2015 |
| PsyGeNET: a knowledge platform on psychiatric disorders and their genes A Gutiérrez-Sacristán, S Grosdidier, O Valverde, M Torrens, À Bravo, ... Bioinformatics 31 (18), 3075-3077, 2015 | 70 | 2015 |
| Network medicine analysis of COPD multimorbidities S Grosdidier, A Ferrer, R Faner, J Piñero, J Roca, B Cosío, A Agustí, ... Respiratory research 15 (1), 1-11, 2014 | 70 | 2014 |
| DisGeNET-RDF: harnessing the innovative power of the Semantic Web to explore the genetic basis of diseases N Queralt-Rosinach, J Piñero, À Bravo, F Sanz, LI Furlong Bioinformatics 32 (14), 2236-2238, 2016 | 62 | 2016 |
| Automatic filtering and substantiation of drug safety signals A Bauer-Mehren, EM Van Mullingen, P Avillach, MC Carrascosa, ... PLoS computational biology 8 (4), e1002457, 2012 | 45 | 2012 |
| Capturing variation impact on molecular interactions in the IMEx Consortium mutations data set N Del-Toro, M Duesbury, M Koch, L Perfetto, A Shrivastava, D Ochoa, ... Nature communications 10 (1), 1-14, 2019 | 39 | 2019 |
| Uncovering disease mechanisms through network biology in the era of Next Generation Sequencing J Piñero, A Berenstein, A Gonzalez-Perez, A Chernomoretz, LI Furlong Scientific Reports 6 (1), 1-12, 2016 | 35 | 2016 |
| Proximal pathway enrichment analysis for targeting comorbid diseases via network endopharmacology J Aguirre-Plans, J Piñero, J Menche, F Sanz, LI Furlong, HHHW Schmidt, ... Pharmaceuticals 11 (3), 61, 2018 | 30 | 2018 |
| The DisGeNET cytoscape app: Exploring and visualizing disease genomics data J Piñero, J Saüch, F Sanz, LI Furlong Computational and structural biotechnology journal 19, 2960-2967, 2021 | 27 | 2021 |
| Genetic and functional characterization of disease associations explains comorbidity C Rubio-Perez, E Guney, D Aguilar, J Piñero, J Garcia-Garcia, B Iadarola, ... Scientific reports 7 (1), 1-14, 2017 | 26 | 2017 |
| Nerve growth factor and striatal glutathione metabolism in a rat model of Huntington's disease R Cruz-Aguado, LF Turner, CM Díaz, J Piñero Restorative neurology and neuroscience 17 (4), 217-221, 2000 | 26 | 2000 |
| In silico models in drug development: where we are J Piñero, LI Furlong, F Sanz Current Opinion in Pharmacology 42, 111-121, 2018 | 23 | 2018 |
| GUILDify v2. 0: a tool to identify molecular networks underlying human diseases, their comorbidities and their druggable targets J Aguirre-Plans, J Piñero, F Sanz, LI Furlong, N Fernandez-Fuentes, ... Journal of molecular biology 431 (13), 2477-2484, 2019 | 19 | 2019 |
| Conservation of key members in the course of the evolution of the insulin signaling pathway JP González, OC Farnés, ATR Vasconcelos, AG Pérez Biosystems 95 (1), 7-16, 2009 | 19 | 2009 |
| A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk P Gomez-Rubio, V Rosato, M Marquez, C Bosetti, E Molina-Montes, ... Annals of Oncology 28 (7), 1618-1624, 2017 | 14 | 2017 |
| Mining the modular structure of protein interaction networks AJ Berenstein, J Piñero, LI Furlong, A Chernomoretz Plos one 10 (4), e0122477, 2015 | 8 | 2015 |
| The eTRANSAFE project on translational safety assessment through integrative knowledge management: achievements and perspectives F Pognan, T Steger-Hartmann, C Díaz, N Blomberg, F Bringezu, K Briggs, ... Pharmaceuticals 14 (3), 237, 2021 | 7 | 2021 |
Laura I. FurlongMedbioinformatics Solutions and GRIB (IMIM-UPF)Verified email at disgenetplus.com
